English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/226419
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Role of Toll Like Receptor 4 in Alzheimer’s Disease

AuthorsCalvo-Rodríguez, María; García-Rodríguez, Carmen ; Villalobos, Carlos ; Núñez, Lucía
KeywordsTLR4
Alzheimer’s disease
Calcium
Amyloid beta oligomers
Aging
Hippocampal neurons
Issue DateAug-2020
PublisherFrontiers Media
CitationFrontiers in Immunology 11: 1588 (2020)
AbstractLong-term evidence has confirmed the involvement of an inflammatory component in neurodegenerative disorders including Alzheimer’s disease (AD). This view is supported, in part, by data suggesting that selected non-steroidal anti-inflammatory drugs (NSAIDs) provide protection. Additionally, molecular players of the innate immune system have recently been proposed to contribute to these diseases. Toll-like receptors (TLRs) are transmembrane pattern-recognition receptors of the innate immune system that recognize different pathogen-derived and tissue damage-related ligands. TLR4 mediated signaling has been reported to contribute to the pathogenesis of age-related neurodegenerative diseases, including AD. Although the pathophysiology of AD is not clear, soluble aggregates (oligomers) of the amyloid β peptide (Aβo) have been proven to be key players in the pathology of AD. Among others, Aβo promote Ca2+ entry and mitochondrial Ca2+ overload leading to cell death in neurons. TLR4 has recently been found to be involved in AD but the mechanisms are unclear. Our group recently reported that lipopolysaccharide (LPS), a TLR4 receptor agonist, increases cytosolic Ca2+ concentration leading to apoptosis. Strikingly, this effect was only observed in long-term cultured primary neurons considered a model of aging neurons, but not in short-term cultured neurons resembling young neurons. These effects were significantly prevented by pharmacological blockade of TLR4 receptor signaling. Moreover, TLR4 expression in rat hippocampal neurons increased significantly in aged neurons in vitro. Therefore, molecular patterns associated with infection and/or brain cell damage may activate TLR4 and Ca2+ signaling, an effect exacerbated during neuronal aging. Here, we briefly review the data regarding the involvement of TLR4 in AD.
Description© 2020 Calvo-Rodriguez, García-Rodríguez, Villalobos and Núñez.
Publisher version (URL)http://dx.doi.org/10.3389/fimmu.2020.01588
URIhttp://hdl.handle.net/10261/226419
DOI10.3389/fimmu.2020.01588
E-ISSN1664-3224
Appears in Collections:(IBGM) Artículos
Files in This Item:
File Description SizeFormat 
Role_Calvo_Art2020.pdf539,95 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.